EPO and anemia: Hematide's lack of erythropoietin immunological cross-reactivity makes it capable of increasing haemoglobin in rats when their anaemia was caused by anti-erythropoietin antibodies that cross-react with endogenous erythropoietin following the administration of recombinant human erythropoietin [6].